LB01: Cell Salvage during Caesarean Section: A Randomised Controlled Trial (The SALVO Trial) - 19/04/17
Doi : 10.1016/j.ajog.2016.11.1047
Khalid Khan 1, Philip Moore 2, Matthew J. Wilson 3, Richard Hooper 1, Shubha Allard 4, Ian Wrench 5, Lee Beresford 1, Tracy Roberts 6, Carol McLoughlin 7, James Geoghegan 8, Jane P. Daniels 7, Sue Catling 9, Vicki A. Clark 10, Paul Ayuk 11, Stephen Robson 12, Fang Gao-Smith 6, Matthew Hogg 13, Doris Lanz 1, Julie Dodds 1
The SALVO Study Group
1 Queen Mary University of London, London, United Kingdom
2 Birmingham Women's Hospital, Birmingham, United Kingdom
3 University of Sheffield, Sheffield, United Kingdom
4 NHS Blood and Transplant, London, United Kingdom
5 Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
6 University of Birmingham, Birmingham, United Kingdom
7 University of Birmingham, London, United Kingdom
8 Birmingham Women's Hospital, London, United Kingdom
9 Singleton Hospital, Swansea, United Kingdom
10 Royal Infirmary, Edinburgh, United Kingdom
11 Royal Victoria Infirmary, Newcastle-upon-Tyne, United Kingdom
12 University of Newcastle, Newcastle-upon-Tyne, United Kingdom
13 Royal London Hospital, London, United Kingdom
Le texte complet de cet article est disponible en PDF.
Plan
© 2016
Publié par Elsevier Masson SAS.
Vol 216 - N° 1S
P. S559 - janvier 2017 Retour au numéro
Article précédent
- Late-Breaking Research Abstracts Divider Page
- LB02: Randomized double-blind placebo controlled evaluation of the safety and efficacy of recombinant Antithrombin versus placebo in preterm preeclampsia
- Baha Sibai, Michael J. Paidas, The PRESERVE Study Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?